MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 249 filers reported holding MIRATI THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $203,895 | -35.1% | 4,500 | 0.0% | 0.03% | -38.9% |
| Q3 2022 | $314,000 | +4.0% | 4,500 | 0.0% | 0.05% | +10.2% |
| Q2 2022 | $302,000 | -18.4% | 4,500 | 0.0% | 0.05% | -2.0% |
| Q1 2022 | $370,000 | -43.9% | 4,500 | 0.0% | 0.05% | -39.8% |
| Q4 2021 | $660,000 | -17.1% | 4,500 | 0.0% | 0.08% | -23.1% |
| Q3 2021 | $796,000 | +9.5% | 4,500 | 0.0% | 0.11% | +11.3% |
| Q2 2021 | $727,000 | -5.7% | 4,500 | 0.0% | 0.10% | -11.8% |
| Q1 2021 | $771,000 | -22.0% | 4,500 | 0.0% | 0.11% | -27.6% |
| Q4 2020 | $988,000 | +32.3% | 4,500 | 0.0% | 0.15% | +13.4% |
| Q3 2020 | $747,000 | +45.3% | 4,500 | 0.0% | 0.13% | +38.1% |
| Q2 2020 | $514,000 | +48.6% | 4,500 | 0.0% | 0.10% | +22.8% |
| Q1 2020 | $346,000 | -40.3% | 4,500 | 0.0% | 0.08% | -19.4% |
| Q4 2019 | $580,000 | – | 4,500 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 2,881,702 | $14,985,000 | 6.99% |
| Avoro Capital Advisors LLC | 2,383,201 | $12,393,000 | 1.58% |
| Broadfin Capital, LLC | 2,090,801 | $10,872,000 | 1.32% |
| Boxer Capital, LLC | 1,037,994 | $5,398,000 | 1.18% |
| Ghost Tree Capital, LLC | 172,184 | $895,000 | 0.17% |
| Baker Brothers Advisors | 2,269,198 | $11,800,000 | 0.10% |
| Hillhouse Capital Management | 725,000 | $3,770,000 | 0.07% |
| SABBY MANAGEMENT, LLC | 249,735 | $1,299,000 | 0.07% |
| Rhenman & Partners Asset Management AB | 50,000 | $260,000 | 0.04% |
| Trexquant Investment LP | 42,879 | $223,000 | 0.03% |